Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Q1 2025 Annual Earnings

RVPH·Reported May 15, 2025·Before market open

Diluted EPS came in at $-0.13 (+48.0% YoY), beat the $-0.21 consensus by $0.08.

Diluted EPS
$-0.13beat by $0.08
Consensus: $-0.21
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001437749-25-010791

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Reviva Pharmaceuticals Holdings, Inc.'s Q1 2025 earnings report.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Q1 2025 earnings on May 15, 2025 before market open.

Reviva Pharmaceuticals Holdings, Inc. reported diluted EPS of $-0.13 for Q1 2025.

EPS beat the consensus estimate of $-0.21 by $0.08.

Compared to the same quarter a year prior, diluted EPS grew 48.0% from $-0.25.

You can read the 10-K periodic report (0001437749-25-010791) directly on SEC EDGAR. The filing index links above go to sec.gov.